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Microscale thermophoresisUpon binding of extracellular ligands, G protein coupled-receptors (GPCRs) initiate signalling cascades by acti-
vating heterotrimeric G proteins through direct interactions with the α subunit. While the lipid dependence of
ligand binding has previously been studied for one class A GPCR, the neurotensin receptor 1 (NTS1), the role
the lipid environment plays in the interaction of activated GPCRs with G proteins is less well understood. It is
therefore of interest to understand the balance of lipid interactions required to support both ligand binding
and G protein activation, not least since some receptors have multiple locations, and may experience different
membrane environments when signalling in the plasma membrane or during endocytosis. Here, using the sen-
sitive biophysical technique of microscale thermophoresis in conjunction with nanodisc lipid bilayer reconstitu-
tion, we show that in more native lipid environments rich in phosphatidyl ethanolamine (PE), the Gαi1 subunit
has a ~4-fold higher afﬁnity for NTS1 than in the absence of native lipids. The G protein-receptor afﬁnity was fur-
ther shown to be dependent on the ligand-binding state of the receptor, with potential indication of biased sig-
nalling for the known antagonist SR142948A. Gαi1 also showed preferential interaction with empty nanodiscs of
native lipidmixtures rich in PE by around 2- to 4-fold over phosphatidyl choline (PC)/phosphatidyl glycerol (PG)
lipid mixtures. The lipid environment may therefore play a role in creating favourable micro-environments for
efﬁcient GPCR signalling. Our approach combining nanodiscs with microscale thermophoresis will be useful in
future studies to elucidate further the complexity of the GPCR interactome.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
G protein-coupled receptors (GPCRs) are the largest class of cell sur-
face receptors, and their pivotal role in cellular signalling is highlighted
by the fact that they form the target for ~40% of marketed pharmaceuti-
cals [1]. They respond to awide array of stimuli, ranging fromhormones
and peptides to ions and photons. Upon ligand binding on the extracel-
lular side of the membrane, GPCRs undergo conformational changes
which lead to the activation of heterotrimeric G proteins on the intracel-
lular side, triggering downstream signalling pathways. The cellular re-
sponse depends on the G protein subtype, and speciﬁc GPCRs can
couple through one or more G protein subtypes, which are typically
classiﬁed by the α subunit of the heterotrimer, with four families iden-
tiﬁed to date: Gs, Gi, Gq, and G12[2,3]. The Gα subunit directly interacts
with the receptor through interactions with the transmembrane (TM)
core (TM3, 5, and 6) and intracellular loops (IC2 and 3) [4–7], which
leads to a large conformational change in the G protein allowing the ex-
change of GDP for GTP in the nucleotide binding pocket, and initiating
downstream signalling, through the α subunit and the βγ heterodimer
[4,8]. Part of the recent crystallographic successwhich has advanced our
understanding of GPCR activation can be attributed to the use of lipidic
mesophases for crystallisation [9], highlighting the importance of thetts).lipid environment for GPCR stability. Indeed, from numerous functional
studies, with a particular emphasis on the prototypical GPCR rhodopsin,
it is clear that the membrane plays an important role in modulating
GPCR activity (recently reviewed in [10]). However, despite often
being used as a model for all other GPCRs, rhodopsin and its membrane
environment present a somewhat unique case in that rhodopsin is the
main protein component (N90%), and thus rod outer segment mem-
branes (which are especially rich in PE and polyunsaturated fatty
acids), will likely have evolved to support rhodopsin function (and/or
vice versa), while the membranes in which other GPCRs function are
more diverse in protein composition [11,12]. Therefore, it is of interest
to test whether previous observations on the lipid preference of rho-
dopsin generalise to other GPCRs.
Neurotensin receptor 1 (NTS1) is a class A GPCR, expressed both in
the brain and in the periphery, with pharmacological potential as target
for treatment of schizophrenia, Parkinson's disease, obesity, and drug
addiction, and as a biomarker for certain cancers, making it an interest-
ing and therapeutically relevant system for functional studies [13].
Stimulation of the receptor by its natural ligand, the tridecapeptide
neurotensin (NT), has been shown to lead to activation of multiple G
protein subtypes: Gs, Gi, and Gq (reviewed in [14]). Mutagenesis studies
have suggested that interactions with IC3 are crucial for Gq activation,
while activation of Gs and Gi requires the presence of the ﬁrst half of
the C-terminus [15–17]. Ligand binding to NTS1 has been shown to be
sensitive to its lipid environment [18]. The presence of phosphatidyl
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discernible ligand-binding activity in phosphatidyl choline (PC) lipids
alone. While the presence of the cholesterol analogue CHS increased
the stability of the receptor (i.e. increased its half-life before ligand-
binding capacity is lost), CHS or cholesterol were not required for ligand
binding [18]. Indeed, ligand binding to NTS1 has been observed in
Escherichia colimembranes which lack cholesterol [19]. Porcine brain
polar lipid extract (BPL, lipid headgroup composition given in
Table S1) best supported receptor ligand-binding activity, demonstrat-
ing that more native lipids are indeed important for receptor ligand-
binding function [18].
Here, we investigate the lipid dependence of the G protein–GPCR in-
teraction by studying the interaction between Gαi1 and NTS1
reconstituted into nanodiscs of different lipid composition usingmicro-
scale thermophoresis (MST). As we previously showed for ligand bind-
ing to detergent-solubilised NTS1 [20], MST allows the determination of
interaction afﬁnities between biomolecules by optically probing the
mobility of a ﬂuorescently labelled molecule in a thermal gradient for
a titration series of an unlabelled binding partner (see Fig. 1). Since
the thermophoretic mobility of a molecule or complex is dependent
on its size, charge and hydration shell [21], binding of the unlabelled
partner to the optically probed species typically affects the
thermophoretic mobility of the latter. Thus, the MST titration experi-
ment yields a saturation binding curve reporting the observed
thermophoresis (ΔFnorm) of the labelled species at different concentra-
tions of the titrated unlabelled binding partner from which interaction
afﬁnities can be obtained [20]. In a novel conﬁguration, MST measure-
ments onwild-type, unmodiﬁed receptorwere facilitated here by label-
ling themembrane scaffold protein (MSP) surrounding the lipid bilayerFig. 1.MST on NTS1 nanodiscs. (a) As shown in this schematic, nanodiscs were produced bymi
tagged (H6) NTS1 (blue) and the MSP belt protein (green). To make ﬂuorescent nanodiscs for
nanodisc formation. Detergent is removed by incubation with Bio-Beads overnight, after whi
nanodiscs are separated from empty nanodiscs by IMAC facilitated by the His-tag on NTS1. (PD
tronmicroscopywere used to image ﬂuorophore-labelled PCPG and BPL nanodiscs (latter show
ple) is prepared to which ~5–25 nM ﬂuorescent nanodiscs is added. Samples are loaded into ca
afterwhich the sample is heated locallywith an IR laser (IR), giving rise to a sudden (~100ms tim
to thermophoresis (III). Both the T-jump and thermophoresis can be inﬂuenced by (bio)molec
inverse temperature jump (IV), and back-diffusion (V) occur. The ﬂuorescence after thermodif
ΔFnorm, which is plotted against the concentration of the titrated binding partner to obtain a biof the nanodiscs with a site-reactive ﬂuorophore, rather than the incor-
porated receptor. While a previous study reported that negatively
charged lipids (i.e. phosphatidyl glycerol lipids) are important for the
Gq–NTS1 interaction [22], we show here that Gαi1 has higher afﬁnity
for the receptor in more native lipid environments that are rich in PE
lipids. Furthermore, we show that ligands modulate the G protein–
GPCR afﬁnity consistent with their pharmacological proﬁle, in agree-
ment with the cubic ternary complex model of ligand–GPCR–G protein
interactions [23], and adding a new dimension to the GPCR interactome
[24].
2. Methods
2.1. NTS1 expression, puriﬁcation, and labelling
An additional 6-His-tag was introduced by QuickChange site-
directed mutagenesis into the NTS1B construct described by White
et al. [25] at the C-terminus of NTS1 before the TEV protease recognition
site to create a new construct, NTS1BH6, to facilitate IMAC on the
cleaved receptor construct lacking the terminal fusion partners.
NTS1BH6 was expressed in E. coli and puriﬁed as described by Harding
et al. [26], with some modiﬁcations. Speciﬁcally, after IMAC on
solubilised lysate, the fusion partners were removed by proteolytic
cleavage with TEV protease, and the receptor was further puriﬁed by
ligand-afﬁnity chromatography using N-terminally Cys-derived NT
(Alta Bioscience) immobilized on Ultralink iodoacetyl resin (Pierce,
Thermo Scientiﬁc) as per the instructions from the supplier. The sample
was incubatedwith the resin for 2–3 h at 4 °C, impurities were removed
by washing sequentially with 70 and 150mMNaCl buffer (50mMTris–xing lipids (grey) solubilised in sodium cholate (orange)with DDM-solubilised (pink) His-
MST, the MSP belt protein was labelled with an Alexa Fluor dye (A647, blue star) prior to
ch nanodiscs are separated from larger aggregates by gel ﬁltration. Finally, NTS1-loaded
B ID 3J00 and 2A01were used for MSP.) (b) Uranyl acetate staining and transmission elec-
n here, see also Fig. S2). (c–d) Schematic of MST setup: a dilution series of G protein (pur-
pillaries, ﬂuorophores are excited by an LED, and the initial ﬂuorescence (F) is detected (I),
e scale) change inﬂuorescence, termed temperature jump (II).Molecules then diffuse due
ular interactions, and thus vary along the titration series. After the IR laser is turned off, an
fusion (III) is normalised to the ﬂuorescence before heating (I) or after T-jump (II) to yield
nding curve [20].
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eluted with 1 M NaCl. NT column eluate was concentrated on a 1 mL
HisTrapNi2+ column (GEHealthcare), and elutedwith 400mM imidaz-
ole. The sample was buffer exchanged by gel ﬁltration on two 5 mL
HiTrap Desalt columns (GE Healthcare) connected in tandem, equili-
brated with NTS1 gel ﬁltration buffer (50 mM Tris–HCl, 50 mM NaCl,
10% glycerol, 0.1% DDM, 0.01% CHS, 1 mM EDTA pH 7.4).
2.2. Gαi1 expression, puriﬁcation, and activity assay
Gαi1 was expressed in E. coli and puriﬁed by metal afﬁnity chroma-
tography using a 5mL HisTrap HP column (GE Healthcare) as described
by Adamson andWatts [24]. Fractions were analysed by SDS-PAGE and
the cleanest fractions were pooled and concentrated using a centrifugal
concentrator (MWCO 10,000 vivaspin20, Sartorius Stedium Biotech),
after which the sample was extensively dialysed against 50 mM Tris–
HCl pH 7.4, 50 mM NaCl, 5 mMMgCl2, 10% (v/v) glycerol at 4 °C. Gαi1
activity was veriﬁed by saturation-binding experimentswith guanosine
5′-O-(3-thiotriphosphate) BODIPY thioester (BODIPY-GTPγS, Molecu-
lar Probes, Life Technologies) using ﬂorescence polarisation measure-
ments at 520 nm on a Pherastar ﬂuorescence plate-reader (BMG, see
SI for details).
2.3. MSP preparation and labelling
A cysteine residue was introduced by QuickChange site-directed
mutagenesis into the MSP1D1 construct at the N-terminus after the
TEVprotease recognition site to facilitate site-directedﬂuorescent label-
ling. The newCys-MSP constructwas expressed in E. coli and puriﬁed by
IMAC on a nickel column as previously described [24]. PuriﬁedMSPwas
dialysed (20 mM Tris–HCl pH 7.4, 0.1 M NaCl, 0.5 mM EDTA) or diluted
with dialysis buffer so that the imidazole concentration was below
20 mM. The 7-His-tag was removed by overnight incubation with TEV
protease at a 1:10 (TEV:MSP) molar ratio and 5 mM DTT. Cleaved MSP
was then separated from TEV, any uncleaved material, and other cleav-
age products by IMAC on a 1 mL HisTrap Ni2+ column, and the ﬂow-
through was collected, followed by a 20 mM imidazole wash to remove
non-speciﬁcally bound cleaved MSP. Fractions were analysed by SDS-
PAGE, pooled and concentrated in vivaspin centrifugal concentrators
(MWCO 10,000). The concentrated sample was reduced with 10 mM
DTT for 1 h at room temperature, after which the reductant was re-
moved by gel ﬁltration using two 5 mL HiTrap Desalt columns connect-
ed in tandem, equilibratedwithMSP dialysis buffer. The freshly reduced
sample was incubated with a small excess (1.7:1 mol:mol) of Alexa
Fluor 647 (A647, Life Technologies) for 3 h at room temperature. Excess
dye was then removed by gel ﬁltration on a 10/30 Superdex 75 column
(GE Healthcare) equilibrated with MSP dialysis buffer. Labelling efﬁ-
ciency was determined from the absorption spectrum.
2.4. Nanodisc preparation
For preparation of nanodiscs, a lipid ﬁlm of the desired composition,
i.e. porcine brain polar lipid (BPL) alone, POPC:POPG (1:1, mol:mol), or
POPC:POPG:BPL (1.5:1:1.07, all purchased from Avanti Polar Lipids),
dried onto a round-bottom ﬂask was resuspended in nanodisc lipid
buffer (50 mM Tris–HCl pH 7.4, 50 mM NaCl, 1 mM EDTA, 100 mM so-
dium cholate) to a ﬁnal lipid concentration of 40 mM, and sonicated
(3 × 1 min) using a bath sonicator at room temperature, followed by 5
freeze–thaw cycles. Lipid was added to NTS1 or to NTS1 gel ﬁltration
buffer for loaded and empty discs, respectively, followed by ﬂuorescent-
ly labelled, cleaved MSP. The ratios in which the components (lipid,
NTS1, and MSP) are added during nanodisc formation are vital to its ef-
ﬁciency. The MSP-to-NTS1 ratio was 50–80 to 1 and the MSP-to-lipid
ratio was 65, 70, and 70 to 1 or 60, 65, and 65 to 1, for PCPG, PCPGBPL,
and BPL empty or loaded nanodiscs, respectively (see also Table S2).
The samples were incubated for 1 h on a rotating wheel at 4 °C. Bio-Beads (SM-2, Bio-Rad) equilibrated in lipid buffer without detergent
were then added to the samples (~1 g ofwet Bio-Beads for a preparation
with 1–4 nmol of NTS1) which were incubated further overnight. After
overnight incubation, the Bio-Beads were exchanged (0.5–1 g) and the
samples were incubated for an additional 2 h, after which the samples
were concentrated to 500 μL using a vivaspin concentrator (MWCO
50,000). Large aggregates were removed by centrifugation (10,000 ×g,
10 min, 4 °C) and the supernatants were ﬁltered (Nanosep MF low-
volume 0.2 μm centrifugal ﬁlter, PALL Corporation). Samples were run
on a gel ﬁltration column (10/30 Superdex 200 column, GE Healthcare)
equilibrated with 50 mMTris–HCl pH 7.4, 50 mMNaCl, 5 mMMgCl2, to
separate nanodiscs from larger aggregates. Fractions were analysed by
SDS-PAGEandpeak fractionswere pooled. For the preparation of loaded
discs, NTS1 containing nanodiscs were separated from empty discs after
gel ﬁltration by IMAC; the samples were loaded onto a 1mL HisTrap HP
column equilibratedwith nanodisc gel ﬁltration buffer, washed with 50
column-volumes of gelﬁltration buffer supplementedwith 2–4mMim-
idazole, after which NTS1 containing nanodiscswere eluted in gel ﬁltra-
tion buffer with 500 mM imidazole. Peak fractions were pooled, and
dialysed against a total of 5 L of gel ﬁltration buffer overnight at 4 °C.
2.5. MST
Microscale thermophoresis experiments were carried out on a blue/
red Monolith NT.115 (NanoTemper Technologies) using the red ﬁlter
set. Samples were centrifuged (10,000 ×g, 10 min, 4 °C) and ﬁltered
(Nanosep MF low-volume 0.2 μm centrifugal ﬁlter) to remove any ag-
gregates. Dilution series (12–16 points) of the unlabelled binding part-
ner were prepared ensuring that no additional gradient (salt, glycerol,
DMSO, etc.) was created by careful buffer matching. Where used, ago-
nist (NT8–13, Sigma Aldrich), antagonist (SR48692 or SR142948A, both
Sanoﬁ), and/or GTPγS (Roche) were added at saturating concentrations
(5 μM, 5 μM, and 0.5 mM, respectively) to all components (ﬂuorescent
binding partner, non-ﬂuorescent binding partner, and buffer) of the ti-
tration series. To minimize adsorption of the sample to the reaction
tubes, LoBind tubes (Eppendorf) were used and Tween 20 was added
at 0.006% (w/v, i.e. below the critical micellar concentration) to all reac-
tion components so as to avoid creation of a Tween 20 gradient in the
dilution series. Under these conditions, the ﬂuorescence was found to
be constant (within±10%) for all points in the titration curve. Themin-
imum amount of ﬂuorescent binding partner needed to give ﬂuores-
cence counts between 200–1500 was determined by a capillary scan
(typically 5–25 nM at 95% LED power). Dilution series were left to incu-
bate at 4 °C for at least 30–60min after which theywere loaded into hy-
drophilic capillaries (NanoTemper Technologies) by capillary action.
Thermophoresis was measured at varying MST power (20, 40, and
80%), with 80% giving the best results. MST data was analysed in
NTAnalysis software (NanoTemper Technologies) and resulting satura-
tion binding curveswere ﬁtted in OriginPro 8.5 (OriginLab) using a one-
site bindingmodel based on the law of mass action, taking into account
ligand depletion, as described by Seidel et al. [20]. An F-test (ﬁt compar-
ison of datasets, OriginPro 8.5) was used to gauge the statistical signiﬁ-
cance of differences between ﬁts of the different datasets (results are
summarised in Table S3). All discussed differenceswere found to be sta-
tistically signiﬁcant unless stated otherwise.
3. Results
3.1. Reconstitution of NTS1 in ﬂuorescent nanodiscs
To assess the effect of lipids on the GPCR–G protein interaction,
nanodiscs of three different lipid compositions were prepared, i.e. BPL,
POPC:POPG:BPL (1.5:1:1.07molar ratio), and POPC:POPG (1:1), the lat-
ter two being hereafter referred to as PCPGBPL and PCPG, respectively.
The discs were ﬂuorescently labelled for MST experiments by attaching
a cysteine-reactive dye (maleimide Alexa Fluor 647) to a cysteine added
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separated from larger material by gel ﬁltration, and the hydrodynamic
radius of the discs was estimated to be ~4.5–5 nm from the elution vol-
umes (Fig. S1). Their morphologywas examined by negative-stain elec-
tron microscopy (EM). A relatively homogeneous population of discs of
the expected size (~10 nmdiameter [27]) was observed for Alexa Fluor-
labelled PCPG and BPL preparations, showing that ﬂuorescently tagging
MSP does not adversely affect overall nanodiscmorphology (Figs. 1 and
S2). Nanodiscs of such size are estimated to provide just over three com-
plete lipid annuli surrounding the NTS1 molecule [24]. The ﬁnal lipid
composition of the BPL nanodiscs was assessed by thin layer chroma-
tography (TLC, Fig. S3). Comparisonwith a number of standards showed
thatwithin the resolution of the technique, theﬁnal lipid composition of
the discs (comprising of both phospholipids and sphingomyelin) was
the same as the initial BPLmixture, but that cholesterol had not been in-
corporated into the discs. However, previous studies have shown that
cholesterol is not required for NTS1 activity [18,19]. While NTS1 has
been shown to dimerise in lipid bilayers [26], the high MSP-to-NTS1
ratio used here to produce nanodiscs (~50–80:1 molar ratio) ensures
that the majority of the discs contain only one receptor. Assuming a
Poisson distribution, the lowest MSP-to-NTS1 molar ratio used (50:1)
would result in b1% of the loaded nanodiscs containing more than one
NTS1 molecule, assuming multimeric insertions are as likely as mono-
meric insertions. In addition, the steric constraints imposed by the
ﬁxed size of the MSP belt, are likely to make the insertion of two NTS1
molecules with a diameter of ~4 nm each into discs with a diameter of
~10 nm to be less favourable than the insertion of a single NTS1 mole-
cule. Furthermore, the calculated probability of multimeric insertion is
based on the incorporation of NTS1 andMSP with the same probability,
while from SDS-PAGE analysis it is evident that a larger proportion of
NTS1 is not incorporated into nanodiscs, eluting as part of larger aggre-
gates in the early void volume fractions (Fig. S1). This results in a higher
effectiveMSP-to-NTS1 ratio than the starting ratio, and thus even lower,
negligible proportions of multimeric nanodisc insertion. The ﬁnal sam-
ple can thus be regarded as representing the monomeric receptor.
3.2. NTS1-Gαi1 interaction
Binding of the G protein α subunit Gαi1 to ﬂuorescently labelled
nanodisc-reconstituted NTS1was investigated in the presence of agonist
(NT) and antagonist (SR48692 or SR142948A, which will be referred to
as SR48 and SR14, respectively, hereafter). The activity of the Gαi1 sub-
unit was veriﬁed by a GTPγS binding assay (Fig. S4). The afﬁnity of the
Gαi1–NTS1 interaction was determined by ﬁtting MST-derived satura-
tion binding curves (Fig. 2) with a one-site binding model accounting
for ligand depletion. The corresponding equilibrium dissociation con-
stant (Kd) values are compiled in Table 1. The afﬁnity of the G protein
for NTS1 was observed to be dependent on the lipid composition of the
nanodiscs, with highest afﬁnity observed for BPL in the presence of ago-
nist (Kd = 140± 60 nM compared to 700 ± 300 and 600± 300 nM for
PCPGBPL and PCPG, respectively). As a negative control G proteinwas in-
cubatedwith GTPγS, a non-hydrolysable analogue of GTP, the binding of
which decouples the G protein from the receptor in vivo. An increase in
Kd was observed under all conditions (Table 1, Kd = 1.5 ± 0.8, 9 ± 5,
and 4 ± 2 μM for BPL, PCPGBPL, and PCPG, respectively), suggesting
that the G protein–NTS1 interaction is indeed speciﬁc. In the absence of
agonist, the afﬁnity of Gαi1 for the BPL-reconstituted receptor decreased
compared to the NT-bound state (from Kd;NT = 140 ± 60 nM to Kd;No li-
gand = 300 ± 100 nM). The effect of agonist on the Gαi1–NTS1 interac-
tions was also seen for PCPG nanodiscs (from Kd;NT = 600 ± 300 nM
to Kd;No ligand = 1.7 ± 0.7 μM), but was not observed for PCPGBPL-
reconstituted NTS1 (Kd;NT = 700 ± 300 nM, and Kd;No ligand = 700 ±
500 nM). This could reﬂect the poor resolution that was obtained for
the PCPGBPL sample in the absence of ligand, with rather large uncer-
tainty in the Kd value for the Gαi1–NTS1 interaction, masking any small
difference that may occur.Addition of antagonist SR48 decreased the afﬁnity of the G protein
for NTS1 approximately 4-fold for BPL and PCPGBPL-reconstituted
NTS1 compared to the agonist-bound state (Table 1), consistentwith in-
verse agonist activity. SR14 appeared to have a weaker antagonist effect
than SR48 (BPL: Kd;SR14 = 300 ± 100 nM vs. Kd;SR48 = 600± 300 nM),
or even a small agonist-like effect compared to the NT-bound or basal
receptor state (PCPGBPL: Kd;SR14 = 500 ± 300 nM vs. Kd;NT = 700 ±
300 nM), although the difference between the two compounds was
not found to be statistically signiﬁcant for the BPL-reconstituted recep-
tor (Table S3). For PCPGnanodiscs, neither antagonist lowered the afﬁn-
ity of Gαi1 for NTS1 with respect to the agonist-bound state, although
higher afﬁnity was observed for both the SR48- and SR14-bound recep-
tor than for the receptor in the basal state (Kd;SR48 = 500 ± 300 and
Kd;SR14 = 600± 300 nM, respectively, vs. Kd;No Ligand = 1.7 ± 0.7 μM;
only the difference with SR48 was statistically signiﬁcant, Table S3).
This suggests that the compounds dobind to the PCPG-reconstituted re-
ceptor, as they can modulate the afﬁnity of the G protein for the recep-
tor, but remarkably, that their effect on the G protein–NTS1 interaction
is similar to that of agonist.Whether this result is relevant to in vivo con-
ditions is unclear, since the PCPG lipid composition is quite different
from the native, mammalian environment of NTS1, which is rich in PE
lipids [12,28,29]. It is thus possible, that the PCPG lipid composition
does not support native NTS1 activity, as suggested by the poor
ligand-binding capability observed previously for NTS1 reconstituted
in PCPG [24].
3.3. Lipid–Gαi1 interaction
Gproteinwas also incubatedwith empty nanodiscs (i.e. not contain-
ing NTS1) to investigate the interaction of the protein with the different
bilayer compositions (Fig. 3). Similarly to the observation for the NTS1-
loaded nanodiscs, the afﬁnity of Gαi1 for empty nanodiscs appears to be
dependent on the lipid composition of the discs (Table 1): G protein in-
teracts with BPL nanodiscs with a Kd of 200± 100 nM, while a lower af-
ﬁnity interaction with Kd = 400 ± 200 nM and Kd = 800 ± 600 nM is
observed for PCPGBPL and PCPG discs, respectively. Addition of GTPγS
signiﬁcantly increased the Kd for all lipid compositions, conﬁrming the
speciﬁcity of the G protein–lipid interaction (Table 1).
4. Discussion
The use of ﬂuorescently labelled MSP is established here as a novel,
general method for performing MST on membrane proteins in a more
physiologically relevant environment than the commonly used deter-
gents. Using labelled MSP bypasses the need for ﬂuorescently labelling
the membrane protein or its binding partner directly, allowing the
use of native, unmodiﬁed proteins, thus providing an alternative
modiﬁcation-free assay conﬁguration for membrane protein studies in
addition to conventional label-free MST [30], which is limited to systems
in which only one of the two binding partners exhibits native UV ﬂuores-
cence. Furthermore, as the nanodisc-reconstituted membrane protein is
theﬂuorescent species in this approach, the experiments require only rel-
atively small amounts of membrane protein at low concentrations (~5–
25 nM), making the approach amenable to challenging systems with
low abundance, such as GPCRs.
The nanodisc-MST approach was employed here to provide insights
into the importance of the lipid environment in the early stages of GPCR
signalling, using a minimal system of only the (lipid-reconstituted) re-
ceptor, the G protein α subunit and ligand. Gαi1 was shown to interact
with nanodisc-reconstituted NTS1 in a lipid-dependent manner, with
the highest afﬁnities obtained for the BPL nanodiscs (Table 1 and
Fig. 2). The afﬁnity of theG protein subunit for the receptor could be fur-
ther modulated by ligand interactions, giving rise to small, but statisti-
cally signiﬁcant differences, suggesting that the interaction of Gαi1
with the NTS1 nanodiscs is governed by the activation state of the re-
ceptor, and is thus speciﬁc.
Fig. 2. Lipid dependence of GPCR–G protein interaction studied by MST. The afﬁnity of Gαi1 for NTS1 is determined by MST experiments in the absence of ligand, in the presence of NT,
SR48, SR14, or NT and GTPγS (negative control). The effect of the lipid environment is tested by doing the experiments in nanodiscs of different lipid composition: (a) PCPG,
(b) PCPGBPL, or (c) BPL. Data was normalised to the amplitude of the sigmoidal binding curve and ﬁtted with a one-site bindingmodel accounting for ligand depletion (red line, the cor-
responding Kd values are shown). Error bars represent the standard error of at least two experiments (see Table 1).
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ing highest afﬁnity for nanodiscs with higher BPL content (Table 1 and
Fig. 3). The afﬁnity of the G protein for the nanodiscs was signiﬁcantly
reduced in the presence of GTPγS, which probably reﬂects the confor-
mational changes that occur in the G protein α subunit upon GTP bind-
ing that lower its afﬁnity for the GPCR [31], and may well affect itsinteractions with other cellular components, including the membrane
itself.
It has to be noted that in thework presented here, only theα subunit
of theG proteinwas used as amodel for theGPCR–Gprotein interaction,
rather than the whole heterotrimer. Previous work, e.g. on rhodopsin
[32] and the δ-opioid receptor [33], has shown that the presence of
Table 1
Afﬁnity of Gαi1 for NTS1 determined byMST. The equilibrium dissociation constants (Kd)
for the interaction between Gαi1 and NTS1 reconstituted into nanodiscs of different lipid
composition (PCPG, PCPGBPL, and BPL) in the presence of different ligands, as determined
fromMST experiments shown in Fig. 2, are given. The interaction betweenGαi1 and empty
nanodiscs (ND) was also studied (see Fig. 3). As a negative control the interactions were
studied in the presence of GTPγS, which decouples the G protein from the receptor. Kd
values were determined with a one-site binding model accounting for ligand depletion,
using the average of n experiments, and the error estimate of the ﬁt is given. An F-test
was used to gauge the statistical signiﬁcance of differences between ﬁts of the different
datasets (results are summarised in Table S3). All differences discussed in the text were
found to be statistically signiﬁcant unless stated otherwise.
Interaction PCPG n PCPGBPL n BPL n
No ligand 1.7 ± 0.7 μM 3 700 ± 500 nM 4 300 ± 100 nM 3
+NT 600 ± 300 nM 4 700 ± 300 nM 4 140 ± 60 nM 4
+SR48 500 ± 300 nM 3 3 ± 2 μM 4 600 ± 300 nM 4
+SR14 600 ± 300 nM 3 500 ± 300 nM 4 300 ± 100 nM 4
+GTPγS 4 ± 2 μM 2 9 ± 5 μM 4 1.5 ± 0.8 μM 3
Empty nanodiscs
+NT 800 ± 600 nM 3 400 ± 200 nM 4 200 ± 100 nM 4
+GTPγS 5 ± 4 μM 3 2 ± 1 μM 3 30 ± 20 μM 2
2894 P.M. Dijkman, A. Watts / Biochimica et Biophysica Acta 1848 (2015) 2889–2897the βγ heterodimer increases the afﬁnity of the G protein for the recep-
tor, although it was also shown that GDP/GTP exchange can take place
at the transducin α subunit in its absence [34]. Furthermore, here Gαi1
was expressed in E. coli, and thus not post-translationally modiﬁed as
it would be in its native environment. G protein α subunit acylation
has been shown to be important for membrane association in the ab-
sence of the βγ heterodimer [34–36]. However, Vögler et al. have
shown that GDP-bound Gi heterotrimers (and the Gβγ heterodimer)
preferentially interact with PE liposomes compared to PC liposomes,
in a PE-ratio dependentmanner [37], which is in agreementwith our re-
sults showing that Gαi1 has the highest afﬁnity for BPL nanodiscs, which
contain the highest proportion of PE lipid of the three lipid mixtures
studied here. In addition, Vögler et al. observed that the GTPγS-bound
Gαi1 showed the opposite behaviour [37]. Indeed, the afﬁnity of
GTPγS-bound Gαi1 was also lowest for BPL nanodiscs here. These com-
bined observations suggest that although G protein acylation and the
presence of the βγ heterodimer increase the afﬁnity of the G proteinFig. 3. G protein–membrane interaction studied by MST. The afﬁnity of Gαi1 for empty nanodis
GTPγS (negative control). The effect of the lipid environment is tested by doing the experimen
normalised to the amplitude of the sigmoidal binding curve and ﬁtted with a one-site binding
Error bars represent the standard error of at least three experiments (see Table 1).for the membrane, they do not affect lipid headgroup preference of
the G protein. Furthermore, the high afﬁnity of Gαi1 for BPL nanodiscs
compared to PCPG discs observed heremight thus be due to the PE con-
tent of the discs [37]. These ﬁndings correlate well with the previously
observed lipid requirements of the receptor for NT binding which im-
plied an important role for PE [18]. Thus, the increased afﬁnity of the
G protein for NTS1 in the presence of higher BPL content, might be
due to stabilisation of the active, agonist-bound state of NTS1 by the na-
tive lipids. Indeed, PE lipids have also been found to play an important
role in the equilibrium between the MI andMII activation states of rho-
dopsin [38–40]. PE is a lipid with a propensity to form non-bilayer
phases, and is abundant in the membranes of the neural system. It is
thought that part of the curvature elastic stress that PE induces inmem-
branes [41] might be relieved by the outward movement of TM6 and
other conformational changes that occur upon GPCR activation [40]. In
addition, PE can form direct and much stronger hydrogen-bonds than
other types of lipids [42], which could contribute to (stabilising) lipid–
protein interactions modulating protein function [40,43]. Thus, the in-
terplay between PE lipids and GPCRs could lower the free energy of
the active state receptor [44], favouring its interaction with G proteins.
In agreement with an earlier plasmon-waveguide resonance study
on opioid receptors [45], the observed afﬁnity of the G protein for
NTS1was ligand dependent,whichwasmost clear for the BPL nanodiscs
where agonist increased the basal afﬁnity, while the antagonists
showed the opposite effect (Table 1), in accordance with their pharma-
cological effect of stimulation or inhibition of signalling. SR14 and SR48
showed a different effect on the Gαi1–NTS1 interaction, with SR48 act-
ing as an inverse agonist (as previously observed [46,47]), reducing
the afﬁnity of the G protein for the receptor more strongly than SR14,
which appeared to function as a neutral antagonist (in all cases but in
PCPG). These results appear to be in agreement with a previous study,
which showed SR14 to be a less potent inverse agonist of Gq- and Gi-
mediated signalling than SR48 in recombinantly NTS1-expressing CHO
cells [48]. However, the broad range of inhibitory activity observed for
SR14 in mice and rats [49,50], and the observation that both SR14 and
SR48 inhibit Fos expression in rat brain [51–53], which has been linked
to Gq-mediatedNTS1 signalling [48], suggest that the inhibitory effect ofcs is determined by MST experiments in the absence of ligand or in the presence of NT and
ts in nanodiscs of different lipid composition: (a) PCPG, (b) PCPGBPL, or (c) BPL. Data was
model accounting for ligand depletion (red line, the corresponding Kd values are shown).
2895P.M. Dijkman, A. Watts / Biochimica et Biophysica Acta 1848 (2015) 2889–2897the compounds could be cell-type and/or G protein subtype-dependent.
Future studies with other G protein subtypes could further address this
possibility of biased antagonism.
Surprisingly, SR48 did not lower the afﬁnity of Gαi1 for PCPG-
reconstituted NTS1 here. Although SR48 has generally been reported
to function as an NTS1 antagonist or inverse agonist, it failed to inhibit
NTS1-mediated calcium ﬂux Xenopus oocytes [54], which have a rela-
tively low PE content (~19mol-%) compared tomammalian brain tissue
(~35 mol-%) [55]. The lack of antagonist behaviour of SR48 at NTS1 in
PCPG and Xenopus oocytes may thus (in part) reﬂect inability of the
non-native nature of those membrane environments to fully support
native signalling behaviour of the receptor. However, as SR48 showed
typical antagonist behaviour in CHO cells which also have a relatively
low PE content (21 mol-% [56]), it remains unclear why SR48 did not
function as an antagonist in Xenopus oocytes, or in PCPG nanodiscs our
current studies.
Lipid dependence of the G protein–GPCR interaction has previously
been shown for other GPCRs. As mentioned, PE lipids have been shown
to be important for the activation of rhodopsin and the afﬁnity of
transducin (Gt) for the receptor [57,58], in agreement with the results
presented here. However, Gt has also been shown to be associated with
negatively charged PS lipids [59]. Such a preferential interaction of G pro-
teinwithnegatively charged lipids could explain the seemingly contradic-
ting results observed in the study on NTS1 by Inagaki et al., where the
apparent afﬁnity of Gq for NTS1 showed positive correlation with the
POPG membrane content relative to POPC [22]. However, the effect of
PE lipids was not investigated in that study; it is thus possible that nega-
tively charged lipids do lead to increased G protein interaction with the
membrane, compared to a zwitterionic PC background, but that PE lipids
do so to a greater extent, or are more important than PG or other anionic
lipid interactions for supporting native receptor function, as observed
here. Indeed, for rhodopsin, NMR studies showed that magnetisation
transfer between the receptor and lipids increased as PC b PS b PE, sug-
gestingpreferential interaction of rhodopsinwith PEover PS [60]. Howev-
er, the study by Inagaki et al. used a different G protein subtype (Gq vs.Gi)
[22], and although they do not differ much structurally, Gαi1 has a more
pronounced negative electrostatic surface potential at the GPCR/bilayer
interface than Gαq which is overall more neutral [31]. Even though
non-complementarity in electrostatic surface potential need not be a bar-
rier to binding [61], the pronounced negative surface potential of Gαi1
may preclude the preference for negatively charged lipids reported previ-
ously for the Gq–NTS1 interaction [22]. Thus, it cannot be excluded that
the lipid dependence of G protein-GPCR interaction is also G protein-
subtype speciﬁc. Indeed, NTS1 has been shown to couple through three
G protein subtypes, and it is possible that the lipid environment of the re-
ceptor plays a role in the G protein subtype selectivity.
The apparent shared lipid environment preferences of the receptor
and the G protein could have implications in vivo, where it might lead
to locally elevated concentrations of both signalling partners, which
would be beneﬁcial for rapid cell response to ligand stimulation. In
turn, the reduced afﬁnity of activated (GTP-bound) Gα for the receptor
and the lipid membrane, which was observed under all studied lipid
compositions, could ensure the decoupling of the α subunit, allowing
it to interact with (cytosolic) downstream signalling targets [34,62–64].
NTS1 has previously been reported to associate transiently with
caveolin-rich microdomains, which could be modulated by addition of
exogenous ceramide, with functional implications for signalling
through Gq [65,66]. Similar observations have been reported for other
GPCRs and G protein subtypes (including Gi, reviewed in [67,68]), al-
though several studies on β-adrenergic receptors have suggested that
the localisation to microdomains may be receptor and G protein sub-
type dependent [69–71]. Thus, although the precise nature of lipid mi-
crodomains remains controversial [72–74], these combined results
suggest that (transient) alterations in the lipid environment of NTS1
can indeed affect its function, and may provide a mechanism for the
modulation of receptor signalling, e.g. G protein speciﬁcity, in vivo.5. Conclusions
Lipid dependence of receptor–G protein interaction and ligand-
receptor binding [18], combined with ligand dependence of G protein
afﬁnity, providesmultidimensional and dynamic scope for GPCRmodu-
lation, and could play a role in ligand-biased signalling of the receptor,
and in cell-type speciﬁc signalling for GPCRs expressed in a variety of
tissues. This work provides useful tools for the study of membrane pro-
tein interactions, and speciﬁcally for future study on how GPCR signal-
ling is further modulated by other components of the GPCR
interactome [24], such as other G protein subtypes, the βγ heterodimer,
and regulatory proteins, aswell as post-translational modiﬁcation of re-
ceptor and G protein, ultimately giving a detailed insight into the regu-
lation of the early stages of GPCR signalling.
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